About Panomics
Panomics is a company based in Fremont (United States) founded in 2000 was acquired by Affymetrix in November 2008. Panomics has raised $48.6 million across 3 funding rounds from investors including Frazier Healthcare Partners, Allen & Company and HBM Healthcare Investments. Panomics offers products and services including TaqMan Real-Time PCR Assays, Ion RNA-Seq, QuantStudio 12K Flex, and GeneChip Arrays. Panomics operates in a competitive market with competitors including Kiyatec, Cellply, Lucid Scientific, CytoTronics and DiscoverX, among others.
- Headquarter Fremont, United States
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
- Legal Name Thermo Fisher Scientific Inc.
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$48.6 M (USD)
in 3 rounds
-
Latest Funding Round
$12.2 M (USD), Series C
Feb 13, 2006
-
Investors
Frazier Healthcare Partners
& 7 more
-
Employee Count
Not available
-
Acquired by
Affymetrix
(Nov 11, 2008)
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Panomics
Panomics offers a comprehensive portfolio of products and services, including TaqMan Real-Time PCR Assays, Ion RNA-Seq, QuantStudio 12K Flex, and GeneChip Arrays.
Assays for detecting gene products in human, mouse, and rat samples.
Sequencing to identify and quantify transcripts in cancer research.
System for real-time PCR gene expression analysis.
Arrays for global gene expression profiling in cancer studies.
People of Panomics
Unlock access to complete
Unlock access to complete
Software Development Team
330 people
Leadership Team
169 people
Sales and Marketing
138 people
Human Resources and Administration
102 people
Product Management Team
68 people
Finance and Accounting
67 people
Senior Team
59 people
Operations Team
52 people
Unlock access to complete
Funding Insights of Panomics
Panomics has successfully raised a total of $48.6M across 3 strategic funding rounds. The most recent funding activity was a Series C round of $12.2 million completed in February 2006. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in Panomics
Panomics has secured backing from 8 investors, including venture fund and institutional investors. Prominent investors backing the company include Frazier Healthcare Partners, Allen & Company and HBM Healthcare Investments.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
-
|
Locked | Locked | Locked | |
|
Venture capital fund backed incubator focused on the healthcare startups
|
Locked | Locked | Locked | |
|
Growth capital is provided by Aravis for Swiss high-tech companies.
|
Locked | Locked | Locked |
Investor details for Panomics
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Panomics
Investment portfolio details for Panomics
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Panomics
Detailed financials for Panomics
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Panomics Comparisons
Peer comparison for Panomics
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Panomics
Panomics operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Kiyatec, Cellply, Lucid Scientific, CytoTronics and DiscoverX, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Kiyatec is focused on revolutionizing cancer care through predictive platforms.
|
|
| Locked | Locked | Locked |
Developer of in-vitro diagnostic products for the detection of cancer
|
|
| Locked | Locked | Locked |
Real-time cell analyzers are developed for oxygen consumption monitoring.
|
|
| Locked | Locked | Locked |
Cell-based assays for drug discovery are developed via CMOS platform.
|
|
| Locked | Locked | Locked |
Develops cell-based assays and provides services for drug discovery and development.
|
|
| Locked | Locked | Locked |
3D cell culture products are developed for drug discovery applications.
|
Detailed competitors of Panomics
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Panomics
Complete news archive for Panomics
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Panomics
Panomics was founded in 2000 and raised its 1st funding round 3 years after it was founded.
Panomics is headquartered in Fremont, United States. It is registered at Fremont, California, United States.
Panomics is a funded company, having raised a total of $48.6M across 3 funding rounds to date.
Panomics was founded in 2000 and is based in Fremont, United States. Cell-based assays and instruments are developed for quantitative multiplexed measurements of molecular events in the biotechnology sector. A suite of assay products is offered for low- to mid-plex applications in genetic, protein, and cellular analysis. Operations center on providing tools for diverse molecular analysis needs across research and development contexts.
Panomics's top competitors include CytoTronics, Kiyatec and Remedy Plan.
Panomics offers TaqMan Real-Time PCR Assays, Ion RNA-Seq, QuantStudio 12K Flex, and GeneChip Arrays.
Panomics has 8 investors. Key investors include Frazier Healthcare Partners, Allen & Company, HBM Healthcare Investments, Affymetrix, and Battelle Ventures.